Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion type Assertion NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_head.
- NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion description "[Thus, combined expression of MYC, EGFR and FGFR2 is predictive of poor survival in CF-treated metastatic gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_provenance.
- NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion evidence source_evidence_literature NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_provenance.
- NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion SIO_000772 21173787 NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_provenance.
- NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion wasDerivedFrom befree-20140225 NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_provenance.
- NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_assertion wasGeneratedBy ECO_0000203 NP813548.RA4bII4alfxi_uE79TYJp-C5PO4pVn0Qf_clT9CvhKf1M130_provenance.